IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Foresite Capital Management IV, LLC

Q3 2025 Holdings

Filed 2025-11-14 | 6 holdings | $182.6M | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Pharvaris N.V.(PHVS)COMN69605108$119.2M4,778,58165.3%
Cytokinetics Inc(CYTK)COM23282W605$25.2M458,29513.8%
Maze Therapeutics, Inc.(MAZE)COM578784100$13.6M522,6577.4%
Lyell Immunopharma, Inc.(LYEL)COM55083R203$13.0M800,3997.1%
Xenon Pharmaceuticals Inc.(XENE)COM98420N105$6.4M160,0003.5%
Relay Therapeutics, Inc.(RLAY)COM75943R102$5.2M1,000,0002.9%